期刊
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
卷 23, 期 6, 页码 1193-+出版社
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.hoc.2009.09.001
关键词
ITP; Thrombopoietin; Thrombocytopenia; Platelets; TPO
资金
- National Institutes of Health [HL82889, HL072299, HL072305]
Since 1968, a greater understanding of platelet biology and its regulation by thrombopoietin (TPO) has emerged. It is now recognized that immune thrombocytopenic purpura (ITP) is a disorder of reduced platelet production as well as increased platelet destruction. New therapies for ITP have emerged that have exploited this new pathophysiologic understanding. This article reviews the biology of TPO, the regulation of its circulating level in ITP, the platelet kinetic data supporting inappropriate platelet production in ITP, and the TPO mimetic agents available to treat ITP.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据